Pricing Log in Create free account
Friday 6 November 2026 Export IMNM’s income statement to Excel — free account

Immunome, Inc.

IMNM Healthcare Biotechnology

Immunome, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.9 million, down 23.2% from fiscal 2024.

Revenue
+69.8%
EPS
−30.0%
Free cash flow
−27.0%

Quarter to June 2026, against a year earlier

18.86 0.95 +5.30%
Market cap
$2.1B
P/E
0.0×
Fwd P/E
−7.6×
Dividend yield
—
F-score
4/9
Altman Z
21.57
Beneish M
n/a
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Immunome, Inc. (IMNM) EV/EBITDA

Alert me on EV/EBITDA

Immunome, Inc. has no meaningful EV/EBITDA: its trailing twelve-month EBITDA is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.6× (January 2021) — the current reading is the lowest in ten years.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 0.0× —
FY2024 0.0× —
FY2023 0.0× —

Quarterly newest first

Period EV/EBITDA Change
Jun 2025 0.0× —
Mar 2025 0.0× —
Dec 2024 0.0× —
Sep 2024 0.0× —
6 more quarters

Against its own ten years

Low 0.0× High 0.6×
Ten-year median 0.0×
Current reading's percentile 97

EV/EBITDA against peers

Company EV/EBITDA
PVLA Palvella Therapeutics, Inc. compare n/m
BHVN Biohaven Ltd. compare n/m
VERA Vera Therapeutics, Inc. compare n/m
CLDX Celldex Therapeutics, Inc. compare n/m
IMNM Immunome, Inc. n/m
LKFT Lakefront Biotherapeutics - Sponsored ADR compare 0.9×
AUPH Aurinia Pharmaceuticals Inc compare 10.5×
ADMA ADMA Biologics Inc compare 13.0×
VCEL Vericel Corporation compare 79.1×
Biotechnology industry median 0.7×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on IMNM